Opioid Pump in Nonmalignant Pain |
Kyeong Dong Jeon, Moo Seong Kim, Se Yeong Pyo, Yeong Gyun Jeong, Sun Il Lee, Yong Tae Jung, Jae Hong Sim, Kim J Burchiel |
Department of Neurosurgery, Inje University Busan Paik Hospital, Busan,Korea OHSU, Portland, OR, USA |
|
Abstract |
Objective Intrathecal drug delivery improves pain relief, reduces suffering, and enhances quality of life in the small proportion of
patients who do not respond well to oral analgesics, including oral morphine.
Method: We perfomed 36 morphine intrathecal pump operation from September 2001 to August, 2002. Preoperation, psychological
test & screening test was tried.
Results Male to female ratio was 1.7:1. Diagnoses were included 32 failed back syndromes, 2 peripheral neuropathies, 1 compression fracture, 1 hip fracture. The average pain rating decresed from 9.3 prior to implantation to 4.9. Mean follow up period was
5.8 months (range 1-11 months). Complications were consisted with 1 infection, 2 revisions.
Conclusion 1) The use of intrathecal opioids in the treatment of patients with nonmalignant pain improves pain relief and quality
of life. 2) Current practices for patient selection and management, screening tests, and dosing guidelines for intrathecal drug
delivery systems, refill are discussed. |
Key Words:
Intrathecal drug, Failed back syndromes, Nonmalignant pain. |
|